{"id":353048,"date":"2026-11-18T15:34:55","date_gmt":"2026-11-18T10:04:55","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=353048"},"modified":"2026-11-18T15:34:55","modified_gmt":"2026-11-18T10:04:55","slug":"decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/","title":{"rendered":"3 Decorative Paints Company, Customer Services Outsourcing Firm and Pharmaceuticals Maker Stocks With a Strong Future Roadmap: Berger Paints India, Firstsource Solutions and Lupin"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Berger Paints India, Firstsource Solutions and Lupin: ROE of 16.3% to 23.8% and FY22 to FY26 revenue CAGR of 8.0% to 15.0%. Prices as of 17 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three <strong>wall paint, call centre and drug stocks<\/strong> to watch are <strong>Berger Paints India<\/strong>, <strong>Firstsource Solutions<\/strong> and <strong>Lupin<\/strong>. Their <strong>return on equity<\/strong> ranges from <strong>16.3% to 23.8%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 8.0% to 15.0%. Lupin leads on both return on equity at 23.8% and revenue growth at 15.0% a year. Prices are based on the 17 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Wall paint, call centre and drug stocks offer a focused view of a sector where demand keeps widening. Berger Paints India, Firstsource Solutions and Lupin cover a decorative paints company, a customer services outsourcing firm and a pharmaceuticals maker.<\/p>\n<p>This list covers three wall paint, call centre and drug stocks with complete current figures: Berger Paints India, Firstsource Solutions and Lupin. Every figure comes from the latest reported financials and the 17 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#What_Are_Wall_Paint_Call_Centre_and_Drug_Stocks\" title=\"What Are Wall Paint, Call Centre and Drug Stocks?\">What Are Wall Paint, Call Centre and Drug Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#Wall_Paint_Call_Centre_and_Drug_Stocks_at_a_Glance\" title=\"Wall Paint, Call Centre and Drug Stocks at a Glance\">Wall Paint, Call Centre and Drug Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#Why_Do_Wall_Paint_Call_Centre_and_Drug_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Wall Paint, Call Centre and Drug Stocks Have a Strong Roadmap in India?\">Why Do Wall Paint, Call Centre and Drug Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#Why_Berger_Paints_India_Features_Among_These_Wall_Paint_Call_Centre_and_Drug_Stocks\" title=\"Why Berger Paints India Features Among These Wall Paint, Call Centre and Drug Stocks\">Why Berger Paints India Features Among These Wall Paint, Call Centre and Drug Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#Why_Firstsource_Solutions_Features_Among_These_Wall_Paint_Call_Centre_and_Drug_Stocks\" title=\"Why Firstsource Solutions Features Among These Wall Paint, Call Centre and Drug Stocks\">Why Firstsource Solutions Features Among These Wall Paint, Call Centre and Drug Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#Why_Lupin_Features_Among_These_Wall_Paint_Call_Centre_and_Drug_Stocks\" title=\"Why Lupin Features Among These Wall Paint, Call Centre and Drug Stocks\">Why Lupin Features Among These Wall Paint, Call Centre and Drug Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#Berger_Paints_India_vs_Firstsource_Solutions_vs_Lupin_on_Key_Financials\" title=\"Berger Paints India vs Firstsource Solutions vs Lupin on Key Financials\">Berger Paints India vs Firstsource Solutions vs Lupin on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#Key_Risks_to_Check_Before_Investing_in_Wall_Paint_Call_Centre_and_Drug_Stocks\" title=\"Key Risks to Check Before Investing in Wall Paint, Call Centre and Drug Stocks\">Key Risks to Check Before Investing in Wall Paint, Call Centre and Drug Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#Final_Thoughts_on_Wall_Paint_Call_Centre_and_Drug_Stocks\" title=\"Final Thoughts on Wall Paint, Call Centre and Drug Stocks\">Final Thoughts on Wall Paint, Call Centre and Drug Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#What_are_wall_paint_call_centre_and_drug_stocks\" title=\"What are wall paint, call centre and drug stocks?\">What are wall paint, call centre and drug stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#Which_wall_paint_call_centre_and_drug_stocks_are_covered_in_this_list\" title=\"Which wall paint, call centre and drug stocks are covered in this list?\">Which wall paint, call centre and drug stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#Why_do_wall_paint_call_centre_and_drug_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do wall paint, call centre and drug stocks have a strong future roadmap in India?\">Why do wall paint, call centre and drug stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#How_has_Berger_Paints_India_performed_financially\" title=\"How has Berger Paints India performed financially?\">How has Berger Paints India performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#How_has_Firstsource_Solutions_performed_financially\" title=\"How has Firstsource Solutions performed financially?\">How has Firstsource Solutions performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#How_has_Lupin_performed_financially\" title=\"How has Lupin performed financially?\">How has Lupin performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#What_risks_should_investors_check_before_buying_wall_paint_call_centre_and_drug_stocks\" title=\"What risks should investors check before buying wall paint, call centre and drug stocks?\">What risks should investors check before buying wall paint, call centre and drug stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/decorative-paints-company-customer-services-outsourcing-firm-and-pharmaceuticals-maker-stocks-roadmap-steppeland-list\/#Is_this_list_of_wall_paint_call_centre_and_drug_stocks_investment_advice\" title=\"Is this list of wall paint, call centre and drug stocks investment advice?\">Is this list of wall paint, call centre and drug stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Wall_Paint_Call_Centre_and_Drug_Stocks\"><\/span><strong>What Are Wall Paint, Call Centre and Drug Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Wall paint, call centre and drug stocks<\/strong> are listed companies that make decorative paints and industrial coatings for homes and factories, provide customer service and back office outsourcing to global firms, and make medicines for India, the United States and other markets. Their earnings depend on housing activity, outsourcing contracts and medicine demand.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Wall_Paint_Call_Centre_and_Drug_Stocks_at_a_Glance\"><\/span><strong>Wall Paint, Call Centre and Drug Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/bergepaint\/berger-paints-india-ltd-share-price-today\">Berger Paints India<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">478.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">54,785<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">45.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">42.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.09<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/fsl\/firstsource-solutions-ltd-share-price-today\">Firstsource Solutions<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">286.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19,489<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.67<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/lupin\/lupin-ltd-share-price-today\">Lupin<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,950<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">89,343<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.29<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Lupin trades at a <strong>P\/E<\/strong> below the industry P\/E, while Berger Paints India and Firstsource Solutions trade above it, which reflects the growth the market already expects. Readers comparing wall paint, call centre and drug stocks should look at <strong>return on equity<\/strong> and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in wall paint, call centre and drug stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Wall_Paint_Call_Centre_and_Drug_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Wall Paint, Call Centre and Drug Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Wall paint, call centre and drug stocks<\/strong> have a strong roadmap in India because strong demand for new and repainted homes, rising outsourcing of customer work and steady demand for medicines keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Paints.<\/strong> Homes need regular painting.<\/li>\n<li><strong>Customer services.<\/strong> Global firms outsource service work.<\/li>\n<li><strong>Pharmaceuticals.<\/strong> Patients need dependable medicines.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Berger_Paints_India_Features_Among_These_Wall_Paint_Call_Centre_and_Drug_Stocks\"><\/span><strong>Why Berger Paints India Features Among These Wall Paint, Call Centre and Drug Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the wall paint, call centre and drug stocks on this list, Berger Paints India is a leading paint maker with decorative, industrial and protective coatings, selling through a wide dealer network across India and in select overseas markets.<\/p>\n<p>Revenue rose from Rs 8,826 crore in FY22 to Rs 11,987 crore in FY26, a compound annual growth rate of 8.0%. Net profit grew from Rs 833 crore in FY22 to Rs 1,128 crore in FY26, which works out to a compound annual growth rate of 7.9%.<\/p>\n<p>In the June 2026 quarter, revenue grew 12.2% year on year to Rs 3,623 crore, while net profit rose 28.6% to Rs 405 crore. The company has a return on equity of 16.3%, a debt to equity ratio of 0.09 and a <strong>market capitalisation<\/strong> of Rs 54,785 crore. The stock trades at a <strong>P\/E<\/strong> of 45.0, above the industry P\/E of 42.6.<\/p>\n<p><strong>Roadmap:<\/strong> The company is expanding capacity and its dealer reach while adding home improvement and waterproofing products. Housing demand and repainting cycles support steady volumes.<\/p>\n<p><strong>What to watch:<\/strong> Track volume growth, new capacity and input costs.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Firstsource_Solutions_Features_Among_These_Wall_Paint_Call_Centre_and_Drug_Stocks\"><\/span><strong>Why Firstsource Solutions Features Among These Wall Paint, Call Centre and Drug Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the decorative coatings, customer service outsourcing and pharma shares on this list, Firstsource Solutions, an RPG group company, is a business process management firm serving banks, healthcare payers and providers, and other clients, mainly in the United States and the United Kingdom.<\/p>\n<p>In the June 2026 quarter, revenue grew 22.8% year on year to Rs 2,731 crore. Revenue rose from Rs 5,922 crore in FY22 to Rs 9,564 crore in FY26, a compound annual growth rate of 12.7%.<\/p>\n<p>Net profit grew from Rs 537 crore in FY22 to Rs 674 crore in FY26, which works out to a compound annual growth rate of 5.9%. The company has a return on equity of 17.1%, a debt to equity ratio of 0.67 and a market capitalisation of Rs 19,489 crore. The stock trades at a P\/E of 29.1, above the industry P\/E of 17.5.<\/p>\n<p><strong>Roadmap:<\/strong> It is growing in healthcare and mortgage services, pursuing larger deals and using artificial intelligence to improve productivity. Longer contracts with large clients give it visibility on revenue.<\/p>\n<p><strong>What to watch:<\/strong> Follow contract wins in healthcare and the pace of new technology investments.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Lupin_Features_Among_These_Wall_Paint_Call_Centre_and_Drug_Stocks\"><\/span><strong>Why Lupin Features Among These Wall Paint, Call Centre and Drug Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Lupin is a Mumbai-headquartered global pharmaceutical company with a presence in branded generics in India, complex generics and specialty products in the United States, and active ingredients, with strength in respiratory, cardiovascular, anti-diabetic and anti-infective therapies.<\/p>\n<p>The company has a return on equity of 23.8%, a debt to equity ratio of 0.29 and a market capitalisation of Rs 89,343 crore. The stock trades at a P\/E of 16.1, below the industry P\/E of 36.0.<\/p>\n<p>Revenue rose from Rs 16,616 crore in FY22 to Rs 29,039 crore in FY26, a compound annual growth rate of 15.0%. Net profit grew from Rs 1,936 crore in FY24 to Rs 5,355 crore in FY26, which works out to a compound annual growth rate of 66.3%. In the June 2026 quarter, revenue grew 32.5% year on year to Rs 8,407 crore, while net profit rose 16.0% to Rs 1,417 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company is building its pipeline of complex generics, inhalation products and biosimilars, and is widening its specialty portfolio in the United States. Its large Indian branded business and a presence in over 100 markets spread revenue across regions and therapies.<\/p>\n<p><strong>What to watch:<\/strong> Track key launches in the United States, especially in inhalation and complex injectables, and the growth of the India branded business.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Berger_Paints_India_vs_Firstsource_Solutions_vs_Lupin_on_Key_Financials\"><\/span><strong>Berger Paints India vs Firstsource Solutions vs Lupin on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three wall paint, call centre and drug stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Berger Paints India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8,826<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11,987<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,128<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Firstsource Solutions<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,922<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9,564<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">674<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Lupin<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16,616<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29,039<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,355<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.4%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Lupin posts the highest return on equity in this group at 23.8%. Lupin combines the largest FY26 revenue at Rs 29,039 crore with the fastest revenue growth, a 15.0% compound annual rate. A useful habit with <strong>wall paint, call centre and drug stocks<\/strong> is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several home paints, BPO services and generic medicines stocks instead of one name, which keeps a single result from deciding the outcome.<\/p>\n<p>The June 2026 quarter, the latest reported, gives a fresh read on momentum:<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY27 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Year-on-Year Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Berger Paints India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,229<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,623<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Firstsource Solutions<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,224<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,731<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Lupin<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,347<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8,407<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">32.5%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Wall_Paint_Call_Centre_and_Drug_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Wall Paint, Call Centre and Drug Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these wall paint, call centre and drug stocks, the main points are: Long-term decorative coatings, customer service outsourcing and pharma shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Housing cycles.<\/strong> Real estate and building demand can vary with rates and sentiment.<\/li>\n<li><strong>Client spending.<\/strong> Technology budgets can vary with global conditions.<\/li>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter wall paint, call centre and drug stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Wall_Paint_Call_Centre_and_Drug_Stocks\"><\/span><strong>Final Thoughts on Wall Paint, Call Centre and Drug Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Wall paint, call centre and drug stocks<\/strong> reward patient research into demand, execution and financial strength. Berger Paints India, Firstsource Solutions and Lupin each have a clear plan to grow. Based on the 17 November 2026 close, Berger Paints India trades at Rs 478.9, Firstsource Solutions at Rs 286.2 and Lupin at Rs 1,950. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these wall paint, call centre and drug stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track wall paint, call centre and drug stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_wall_paint_call_centre_and_drug_stocks\"><\/span><strong>What are wall paint, call centre and drug stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Wall paint, call centre and drug stocks are listed companies that make decorative paints and industrial coatings for homes and factories, provide customer service and back office outsourcing to global firms, and make medicines for India, the United States and other markets. Their earnings depend on housing activity, outsourcing contracts and medicine demand. This list looks at three of them, Berger Paints India, Firstsource Solutions and Lupin, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_wall_paint_call_centre_and_drug_stocks_are_covered_in_this_list\"><\/span><strong>Which wall paint, call centre and drug stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Berger Paints India, Firstsource Solutions and Lupin. Based on the 17 November 2026 close, Berger Paints India traded at Rs 478.9, Firstsource Solutions at Rs 286.2 and Lupin at Rs 1,950. Their return on equity ranges from <strong>16.3% to 23.8%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 8.0% to 15.0%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_wall_paint_call_centre_and_drug_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do wall paint, call centre and drug stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> <strong>Wall paint, call centre and drug stocks<\/strong> have a strong roadmap in India because strong demand for new and repainted homes, rising outsourcing of customer work and steady demand for medicines keep widening the market for these companies. The main drivers are as follows. Paints. Homes need regular painting. Customer services. Global firms outsource service work. Pharmaceuticals. Patients need dependable medicines. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Berger_Paints_India_performed_financially\"><\/span><strong>How has Berger Paints India performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 8,826 crore in FY22 to Rs 11,987 crore in FY26, a compound annual growth rate of 8.0%. Net profit grew from Rs 833 crore in FY22 to Rs 1,128 crore in FY26, which works out to a compound annual growth rate of 7.9%. In the June 2026 quarter, revenue grew 12.2% year on year to Rs 3,623 crore, while net profit rose 28.6% to Rs 405 crore. The company has a return on equity of 16.3%, a debt to equity ratio of 0.09 and a market capitalisation of Rs 54,785 crore. The stock trades at a P\/E of 45.0, above the industry P\/E of 42.6. Looking ahead, the company is expanding capacity and its dealer reach while adding home improvement and waterproofing products. Housing demand and repainting cycles support steady volumes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Firstsource_Solutions_performed_financially\"><\/span><strong>How has Firstsource Solutions performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 5,922 crore in FY22 to Rs 9,564 crore in FY26, a compound annual growth rate of 12.7%. Net profit grew from Rs 537 crore in FY22 to Rs 674 crore in FY26, which works out to a compound annual growth rate of 5.9%. In the June 2026 quarter, revenue grew 22.8% year on year to Rs 2,731 crore. The company has a return on equity of 17.1%, a debt to equity ratio of 0.67 and a market capitalisation of Rs 19,489 crore. The stock trades at a P\/E of 29.1, above the industry P\/E of 17.5. Looking ahead, it is growing in healthcare and mortgage services, pursuing larger deals and using artificial intelligence to improve productivity. Longer contracts with large clients give it visibility on revenue.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Lupin_performed_financially\"><\/span><strong>How has Lupin performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 16,616 crore in FY22 to Rs 29,039 crore in FY26, a compound annual growth rate of 15.0%. Net profit grew from Rs 1,936 crore in FY24 to Rs 5,355 crore in FY26, which works out to a compound annual growth rate of 66.3%. In the June 2026 quarter, revenue grew 32.5% year on year to Rs 8,407 crore, while net profit rose 16.0% to Rs 1,417 crore. The company has a return on equity of 23.8%, a debt to equity ratio of 0.29 and a market capitalisation of Rs 89,343 crore. The stock trades at a P\/E of 16.1, below the industry P\/E of 36.0. Looking ahead, the company is building its pipeline of complex generics, inhalation products and biosimilars, and is widening its specialty portfolio in the United States. Its large Indian branded business and a presence in over 100 markets spread revenue across regions and therapies.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_wall_paint_call_centre_and_drug_stocks\"><\/span><strong>What risks should investors check before buying wall paint, call centre and drug stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying wall paint, call centre and drug stocks. Housing cycles. Real estate and building demand can vary with rates and sentiment. Client spending. Technology budgets can vary with global conditions. Regulatory approvals. Plant inspections and approvals can affect supplies. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_wall_paint_call_centre_and_drug_stocks_investment_advice\"><\/span><strong>Is this list of wall paint, call centre and drug stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are wall paint, call centre and drug stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Wall paint, call centre and drug stocks are listed companies that make decorative paints and industrial coatings for homes and factories, provide customer service and back office outsourcing to global firms, and make medicines for India, the United States and other markets. Their earnings depend on housing activity, outsourcing contracts and medicine demand. This list looks at three of them, Berger Paints India, Firstsource Solutions and Lupin, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which wall paint, call centre and drug stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Berger Paints India, Firstsource Solutions and Lupin. Based on the 17 November 2026 close, Berger Paints India traded at Rs 478.9, Firstsource Solutions at Rs 286.2 and Lupin at Rs 1,950. Their return on equity ranges from 16.3% to 23.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.0% to 15.0%.\"}},{\"@type\":\"Question\",\"name\":\"Why do wall paint, call centre and drug stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Wall paint, call centre and drug stocks have a strong roadmap in India because strong demand for new and repainted homes, rising outsourcing of customer work and steady demand for medicines keep widening the market for these companies. The main drivers are as follows. Paints. Homes need regular painting. Customer services. Global firms outsource service work. Pharmaceuticals. Patients need dependable medicines. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Berger Paints India performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 8,826 crore in FY22 to Rs 11,987 crore in FY26, a compound annual growth rate of 8.0%. Net profit grew from Rs 833 crore in FY22 to Rs 1,128 crore in FY26, which works out to a compound annual growth rate of 7.9%. In the June 2026 quarter, revenue grew 12.2% year on year to Rs 3,623 crore, while net profit rose 28.6% to Rs 405 crore. The company has a return on equity of 16.3%, a debt to equity ratio of 0.09 and a market capitalisation of Rs 54,785 crore. The stock trades at a P\/E of 45.0, above the industry P\/E of 42.6. Looking ahead, the company is expanding capacity and its dealer reach while adding home improvement and waterproofing products. Housing demand and repainting cycles support steady volumes.\"}},{\"@type\":\"Question\",\"name\":\"How has Firstsource Solutions performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 5,922 crore in FY22 to Rs 9,564 crore in FY26, a compound annual growth rate of 12.7%. Net profit grew from Rs 537 crore in FY22 to Rs 674 crore in FY26, which works out to a compound annual growth rate of 5.9%. In the June 2026 quarter, revenue grew 22.8% year on year to Rs 2,731 crore. The company has a return on equity of 17.1%, a debt to equity ratio of 0.67 and a market capitalisation of Rs 19,489 crore. The stock trades at a P\/E of 29.1, above the industry P\/E of 17.5. Looking ahead, it is growing in healthcare and mortgage services, pursuing larger deals and using artificial intelligence to improve productivity. Longer contracts with large clients give it visibility on revenue.\"}},{\"@type\":\"Question\",\"name\":\"How has Lupin performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 16,616 crore in FY22 to Rs 29,039 crore in FY26, a compound annual growth rate of 15.0%. Net profit grew from Rs 1,936 crore in FY24 to Rs 5,355 crore in FY26, which works out to a compound annual growth rate of 66.3%. In the June 2026 quarter, revenue grew 32.5% year on year to Rs 8,407 crore, while net profit rose 16.0% to Rs 1,417 crore. The company has a return on equity of 23.8%, a debt to equity ratio of 0.29 and a market capitalisation of Rs 89,343 crore. The stock trades at a P\/E of 16.1, below the industry P\/E of 36.0. Looking ahead, the company is building its pipeline of complex generics, inhalation products and biosimilars, and is widening its specialty portfolio in the United States. Its large Indian branded business and a presence in over 100 markets spread revenue across regions and therapies.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying wall paint, call centre and drug stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying wall paint, call centre and drug stocks. Housing cycles. Real estate and building demand can vary with rates and sentiment. Client spending. Technology budgets can vary with global conditions. Regulatory approvals. Plant inspections and approvals can affect supplies. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of wall paint, call centre and drug stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Wall Paint, Call Centre and Drug Stocks with a strong future roadmap: Berger Paints India, Firstsource Solutions and Lupin. Compare price, valuation, return on equity and revenue growth as of 17 November 2026.<\/p>\n","protected":false},"author":36,"featured_media":353041,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[8578,3803,25817,25813,25815,25814,7676,25816,13958,25812],"class_list":["post-353048","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-berger-paints-india","tag-best-stocks","tag-bpo-services-and-generic-medicines-stocks","tag-call-centre-and-drug-stocks","tag-customer-service-outsourcing-and-pharma-shares","tag-decorative-coatings","tag-firstsource-solutions","tag-home-paints","tag-lupin","tag-wall-paint"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["353041"],"rank_math_title":["Wall Paint, Call Centre and Drug Stocks"],"rank_math_description":["Compare 3 wall paint, call centre and drug stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 17 Nov 2026."],"rank_math_focus_keyword":["wall paint, call centre and drug stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-decorative-paints-company-customer-services-outsourcing-firm-and.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=353048"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353048\/revisions"}],"predecessor-version":[{"id":353050,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353048\/revisions\/353050"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/353041"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=353048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=353048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=353048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}